To the full analysis
Buyback calculator for STAAR Surgical
STAAR Surgical stock: key metrics
STAASTAAR Surgical had an operating margin of −19.2% and a return on invested capital (ROIC) of −18.1% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 47.0% | −24.2% | −26.7% |
| 2007 | 49.3% | −23.8% | −27.0% |
| 2008 | 53.6% | −27.2% | −31.0% |
| 2009 | 55.6% | −4.9% | −8.2% |
| 2010 | 63.8% | −4.7% | 0.1% |
| 2011 | 67.5% | 4.4% | 2.1% |
| 2012 | 69.4% | −1.9% | −2.8% |
| 2013 | 69.7% | 1.0% | 0.6% |
| 2014 | 65.1% | −10.7% | −11.2% |
| 2015 | 68.4% | −6.9% | −8.5% |
| 2016 | 70.8% | −15.4% | −14.7% |
| 2017 | 70.9% | −4.0% | −2.4% |
| 2018 | 73.8% | 5.3% | 4.0% |
| 2019 | 74.5% | 7.9% | 9.4% |
| 2020 | 72.4% | 4.1% | 3.6% |
| 2021 | 77.5% | 14.5% | 11.9% |
| 2022 | 78.5% | 15.4% | 13.9% |
| 2023 | 78.4% | 8.7% | 6.6% |
| 2024 | 76.3% | −4.0% | −6.4% |
| 2025 | 76.2% | −19.2% | −33.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −47.4% | −39.6% | −31.5% |
| 2007 | −44.2% | −38.1% | −29.5% |
| 2008 | −100.0% | −62.8% | −44.1% |
| 2009 | −29.4% | −13.7% | −10.6% |
| 2010 | 0.2% | −10.1% | 0.1% |
| 2011 | 4.6% | 8.1% | 2.8% |
| 2012 | −5.6% | −5.6% | −3.2% |
| 2013 | 1.0% | 1.8% | 0.6% |
| 2014 | −22.6% | −25.3% | −14.2% |
| 2015 | −16.8% | −14.2% | −10.4% |
| 2016 | −32.0% | −32.8% | −18.5% |
| 2017 | −5.0% | −9.3% | −3.1% |
| 2018 | 3.8% | 15.3% | 3.0% |
| 2019 | 8.8% | 28.4% | 6.8% |
| 2020 | 3.0% | 9.2% | 2.3% |
| 2021 | 10.6% | 40.0% | 8.0% |
| 2022 | 11.8% | 31.0% | 9.5% |
| 2023 | 5.5% | 10.0% | 4.4% |
| 2024 | −5.1% | −4.9% | −4.0% |
| 2025 | −23.4% | −18.1% | −17.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 2 Jan 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 21 Feb 2025)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.